Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV

The Lancet HIV in conversation with

The Lancet HIV in conversation with
Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV
Jul 01, 2025
The Lancet Group

In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results.

Read the full article:

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00041-4/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Episode Artwork Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV 16:23 Episode Artwork Grace Lui and Vincent Wong on lifestyle modifications to address MASLD in people with HIV 13:50 Episode Artwork Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality 24:00 Episode Artwork Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes 21:28 Episode Artwork Lisa Noguchi and Nyaradzo Mgodi on HIV prophylactic dapivirine ring in breastfeeding women 23:02 Episode Artwork Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure 23:55 Episode Artwork Claudia Cortes y Giovanni Ravasi sobre VIH y migración (in Spanish) 33:29 Episode Artwork Florence Riako Anam and Bruce Richman on U=U 24:50 Episode Artwork Peter Hayward on 10 years of The Lancet HIV 22:18 Episode Artwork Salome Kuchukidze and Souleymane Diabaté on the link between intimate partner violence and vertical HIV transmission in sub-Saharan Africa 23:15 Episode Artwork José M. Zuniga on the future of urban HIV responses Commission 21:43 Episode Artwork Alejandro García sobre los tiempos de transición en la atención médica continuada del VIH en España (ES) 24:37 Episode Artwork Serge Eholie on treatments for HIV-2 25:42 Episode Artwork Drew Voetsch and Robert Selato on achieving the 95-95-95 UNAIDS goals in Botswana 21:09 Episode Artwork Adam Trickey on trends in causes of death among people with HIV in Europe and North America 10:54 Episode Artwork Manik Kohli, Iain Reeves, and Laura Waters on homophobia in the provision of sexual health care in the UK 40:47 Episode Artwork Lulu Nair, Connie Celum, and Kenneth Ngure on dapivirine vaginal ring and daily oral PrEP for HIV prevention in women 14:04 Episode Artwork Sophia Rein on HIV treatment with INSTIs and cardiovascular events 14:11 Episode Artwork Lawrence Mbuagbaw on reporting of HIV drug resistance in clinical studies using the CEDRIC-HIV checklist 8:20 Episode Artwork Andreas Jahn and Nellie Wadonda-Kabondo on trends in HIV prevalence and incidence 23:10 Episode Artwork Eryn Braley and Mckenzie Braley on experiences of HIV among global Indigenous populations 20:16 Episode Artwork Ricardo Luque and Miguel Barriga on HIV prevalence and care continuum among migrants from Venezuela in Colombia (en Español) 44:04 Episode Artwork Denton Callander on the effects of treatment as prevention 17:55 Episode Artwork Andrea Wirtz and Sari Reisner on HIV incidence and mortality among transgender women 25:02 Episode Artwork Yasmin Mohamed on early infant diagnosis of HIV 16:21